Iron-Deficiency Anemia in Infants in Two Weekly Programs (IDA)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00655408|
Recruitment Status : Completed
First Posted : April 9, 2008
Last Update Posted : April 9, 2008
|Condition or disease||Intervention/treatment||Phase|
|Anemia||Drug: elemental iron||Not Applicable|
Some studies have shown satisfactory results in reducing the prevalence of iron deficiency using weekly doses of ferrous sulfate, thereby avoiding these side effects. This deficiency is the most common nutritional disorder during childhood and does not only affect individuals from developing countries but also those from industrialized nations.
For infants with ages between six and 24 months, iron supplementation is the main treatment for iron deficiency. In this age range the prevalence of anemia is at least 20%. However, studies have shown a low rate of compliance by mothers during the recommended period, which may be caused by a lack of care or, more probably, due to the side effects caused by long-term daily ferrous sulfate supplementation, which include nausea, vomiting, diarrhea, staining of teeth and abdominal pain.
This specific study is randomized clinical trial study, achieved in a government healthcare clinic in Sao Jose do Rio Preto, Sao Paulo, Brazil. This study was carried out using two intervention groups. All children received 12 weekly doses of 25 mg of elemental iron, either administered in the government healthcare clinic or at the children's home.
The study showed treatment compliance in both groups. Prevalence of anemia for all children was 75% at the beginning of supplementation and 46.3% at the end of the period (p < 0.0005). Reduction rate for anemic children was 38.3%. Average increases in hemoglobin concentration levels were 0.75 g/dL and 0.65 g/dL, respectively, for home interventions and healthcare clinic administration (p < 0.00005).
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||130 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Iron-Deficiency Anemia in Infants: Comparative Study of Two Weekly Supplement Programs|
|Study Start Date :||April 2003|
|Actual Primary Completion Date :||September 2003|
|Actual Study Completion Date :||January 2004|
Active Comparator: A
For infants with ages between six and 24 months, iron supplementation is the main treatment for iron deficiency.This study was carried out using two intervention groups. All children received 12 weekly doses of 25 mg of elemental iron.
Group 1 administered in the government healthcare clinic. Group 2 administered children's home.
The study showed treatment compliance in both groups.
Drug: elemental iron
Other Name: doses of 25 mg of elemental iron
- Test (serum hemoglobin) [ Time Frame: assessed at the before of the treatment period ]
- Test (serum hemoglobin) [ Time Frame: assessed after 12 weekly with iron supplement ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00655408
|Principal Investigator:||Coutinho Geraldo Gaspar Paes Leme, MD||University Medical School f São Jose do Rio Preto-Brazil|